Aquestive Therapeutics, Inc. ($AQST)
Filing Information
| Accession Number | 0001214659-26-003141 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
168,291
Total Value
$191,085.84
P&L
+inf% (+$487,550.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Mar 9, 2026 | Grant/Award | 80,000 | $0.00 | $0.00 | 320,771 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 10, 2026 | Sale | 45,791 | $4.17 | $191,085.84 | 274,980 | Direct | โ | View Details | |
Chief Operating Officer | Non-Qualified Stock Option (right to buy) | Derivative | Mar 9, 2026 | Grant/Award | 42,500 | $0.00 | $0.00 | 42,500 | Direct | โ | View Details |